Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Affirm Holdings, Inc. stock logo
AFRM
Affirm
$69.04
+1.0%
$55.95
$22.25
$82.53
$22.27B3.638.35 million shs2.30 million shs
Arch Biopartners Inc. stock logo
ARCH
Arch Biopartners
$134.83
$134.83
$116.44
$177.88
N/AN/A379,212 shsN/A
Moderna, Inc. stock logo
MRNA
Moderna
$30.47
+0.6%
$26.59
$23.15
$129.39
$11.78B1.848.67 million shs6.97 million shs
 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Affirm Holdings, Inc. stock logo
AFRM
Affirm
+1.89%+3.20%+29.24%+75.71%+132.71%
Arch Biopartners Inc. stock logo
ARCH
Arch Biopartners
0.00%0.00%0.00%0.00%+13,482,999,900.00%
Moderna, Inc. stock logo
MRNA
Moderna
+5.54%+12.73%+11.94%+17.68%-74.14%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Affirm Holdings, Inc. stock logo
AFRM
Affirm
2.13 of 5 stars
2.43.00.00.01.83.30.6
Arch Biopartners Inc. stock logo
ARCH
Arch Biopartners
N/AN/AN/AN/AN/AN/AN/AN/A
Moderna, Inc. stock logo
MRNA
Moderna
4.3803 of 5 stars
4.02.00.04.61.22.50.6
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Affirm Holdings, Inc. stock logo
AFRM
Affirm
2.73
Moderate Buy$65.67-4.88% Downside
Arch Biopartners Inc. stock logo
ARCH
Arch Biopartners
0.00
N/AN/AN/A
Moderna, Inc. stock logo
MRNA
Moderna
2.04
Hold$46.6152.97% Upside

Current Analyst Ratings Breakdown

Latest ARCH, MRNA, and AFRM Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
7/2/2025
Affirm Holdings, Inc. stock logo
AFRM
Affirm
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingHold ➝ Hold
6/30/2025
Affirm Holdings, Inc. stock logo
AFRM
Affirm
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight
6/30/2025
Affirm Holdings, Inc. stock logo
AFRM
Affirm
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$67.00 ➝ $80.00
6/12/2025
Affirm Holdings, Inc. stock logo
AFRM
Affirm
Stephens
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageEqual Weight$69.00
6/9/2025
Affirm Holdings, Inc. stock logo
AFRM
Affirm
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$53.00 ➝ $67.00
6/5/2025
Affirm Holdings, Inc. stock logo
AFRM
Affirm
Royal Bank Of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingSector Perform ➝ Sector Perform$70.00
6/2/2025
Affirm Holdings, Inc. stock logo
AFRM
Affirm
Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy$58.00
6/2/2025
Moderna, Inc. stock logo
MRNA
Moderna
William Blair
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingMarket Perform
5/22/2025
Moderna, Inc. stock logo
MRNA
Moderna
JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetUnderweight ➝ Underweight$33.00 ➝ $26.00
5/12/2025
Affirm Holdings, Inc. stock logo
AFRM
Affirm
The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$45.00 ➝ $58.00
5/12/2025
Affirm Holdings, Inc. stock logo
AFRM
Affirm
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$45.00 ➝ $53.00
(Data available from 7/3/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Affirm Holdings, Inc. stock logo
AFRM
Affirm
$2.32B9.59N/AN/A$8.78 per share7.86
Arch Biopartners Inc. stock logo
ARCH
Arch Biopartners
N/AN/AN/AN/AN/AN/A
Moderna, Inc. stock logo
MRNA
Moderna
$3.14B3.75N/AN/A$28.33 per share1.08
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Affirm Holdings, Inc. stock logo
AFRM
Affirm
-$517.76M-$0.21N/A111.352.44-2.07%-2.22%-0.61%8/27/2025 (Estimated)
Arch Biopartners Inc. stock logo
ARCH
Arch Biopartners
N/AN/A0.00N/AN/AN/AN/AN/A
Moderna, Inc. stock logo
MRNA
Moderna
-$3.56B-$8.73N/AN/AN/A-105.67%-28.69%-21.94%7/30/2025 (Estimated)

Latest ARCH, MRNA, and AFRM Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/8/2025Q3 2025
Affirm Holdings, Inc. stock logo
AFRM
Affirm
-$0.09$0.01+$0.10$0.01$782.98 million$783.14 million
5/1/2025Q1 2025
Moderna, Inc. stock logo
MRNA
Moderna
-$2.92-$2.52+$0.40-$2.52$130.35 million$108.00 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Affirm Holdings, Inc. stock logo
AFRM
Affirm
N/AN/AN/AN/AN/A
Arch Biopartners Inc. stock logo
ARCH
Arch Biopartners
N/AN/AN/AN/AN/A
Moderna, Inc. stock logo
MRNA
Moderna
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Affirm Holdings, Inc. stock logo
AFRM
Affirm
2.55
11.47
11.47
Arch Biopartners Inc. stock logo
ARCH
Arch Biopartners
N/AN/AN/A
Moderna, Inc. stock logo
MRNA
Moderna
N/A
4.22
4.14

Institutional Ownership

CompanyInstitutional Ownership
Affirm Holdings, Inc. stock logo
AFRM
Affirm
69.29%
Arch Biopartners Inc. stock logo
ARCH
Arch Biopartners
N/A
Moderna, Inc. stock logo
MRNA
Moderna
75.33%

Insider Ownership

CompanyInsider Ownership
Affirm Holdings, Inc. stock logo
AFRM
Affirm
11.82%
Arch Biopartners Inc. stock logo
ARCH
Arch Biopartners
N/A
Moderna, Inc. stock logo
MRNA
Moderna
11.00%
CompanyEmployeesShares OutstandingFree FloatOptionable
Affirm Holdings, Inc. stock logo
AFRM
Affirm
2,006322.60 million284.47 millionOptionable
Arch Biopartners Inc. stock logo
ARCH
Arch Biopartners
N/AN/AN/AN/A
Moderna, Inc. stock logo
MRNA
Moderna
5,800386.74 million344.20 millionOptionable

Recent News About These Companies

RFK Jr. Just Did The Unexpected. He Helped Moderna.
Moderna Stock Gains on Encouraging Flu Vaccine Data
Moderna flu vaccine shows superior results in phase 3 study
Moderna flu vaccine trial results clear path for combo shot
Moderna shines spotlight on new flu vaccine data
Moderna’s flu vaccine hits goal, paving way for combo shot

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Affirm stock logo

Affirm NASDAQ:AFRM

$69.04 +0.67 (+0.97%)
Closing price 03:57 PM Eastern
Extended Trading
$68.94 -0.10 (-0.14%)
As of 04:55 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Affirm Holdings, Inc. operates a platform for digital and mobile-first commerce in the United States, Canada, and internationally. The company's platform includes point-of-sale payment solution for consumers, merchant commerce solutions, and a consumer-focused app. Its commerce platform, agreements with originating banks, and capital markets partners enables consumers to pay for a purchase over time with terms ranging up to 60 months. The company has active merchants covering small businesses, large enterprises, direct-to-consumer brands, brick-and-mortar stores, and companies with an omni-channel presence. Its merchants represent a range of industries, including sporting goods and outdoors, furniture and homewares, travel and ticketing, apparel, accessories, consumer electronics, and jewelry. Affirm Holdings, Inc. was founded in 2012 and is headquartered in San Francisco, California.

Arch Biopartners stock logo

Arch Biopartners NYSE:ARCH

$134.83 0.00 (0.00%)
As of 01/14/2025

Moderna stock logo

Moderna NASDAQ:MRNA

$30.47 +0.19 (+0.63%)
Closing price 03:58 PM Eastern
Extended Trading
$30.50 +0.03 (+0.08%)
As of 04:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, autoimmune, and cardiovascular diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, influenza, and respiratory syncytial virus, spikevax, and hMPV/PIV3 vaccines; latent vaccines comprise cytomegalovirus, epstein-barr virus, herpes simplex virus, varicella zoster virus, and human immunodeficiency virus vaccines; public health vaccines consists of Zika, Nipah, Mpox vaccines; and infectious diseases vaccines, such as lyme and norovirus vaccines. The company also offers systemic secreted and cell surface therapeutics; cancer vaccines, such as personalized cancer, KRAS, and checkpoint vaccines; intratumoral immuno-oncology products; rare disease intracellular therapeutics; and inhaled pulmonary therapeutics. It has strategic alliances and collaborations with AstraZeneca; Merck & Co., Inc; Vertex Pharmaceuticals Incorporated; Vertex Pharmaceuticals (Europe) Limited; Chiesi Farmaceutici S.p.A.; Metagenomi, Inc.; Carisma Therapeutics, Inc.; CytomX Therapeutics; Defense Advanced Research Projects Agency; Biomedical Advanced Research and Development Authority; Institute for Life Changing Medicines; and The Bill & Melinda Gates Foundation. The company was formerly known as Moderna Therapeutics, Inc. and changed its name to Moderna, Inc. in August 2018. Moderna, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts.